Fifth Dimension    Catalog    Contact Us
graphic to create line
Cancer Supportive and Survivorship Care Programs Improving Quality of Life Logo

Diet & Prostate Cancer References
Natalie Ledesma, MS, RD

References - Diet and Prostate Cancer

1. Byers T, Nestle M, McTiernan A, Doyle C, Currie-Williams A, Gansler T, et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. American Cancer Society 2001 Nutrition and Physical Activity Guidelines Advisory Committee. CA: A Cancer J for Clin. 2002;52(2):92-119.
2. Ornish D, Weidner G, Fair WR, Marlin R, Pettengill EB. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol. 2005;174(3):1065-1069.
3. Saxe GA, Major JM, Nguyen JY, Freeman KM, Downs TM. Potential attenuation of disease progression in recurrent prostate cancer with plant-based diet and stress reduction. Integr Cancer Ther. 2006;5(3):206-213.
4. Dubenmier JJ, Weidner G, Marlin R, Crutchfield L, Dunn-Emke S. Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillance. Urol. 2006;67(1):125-130.
5. Sunny L. A low fat diet rich in fruits and vegetables may reduce the risk of developing prostate cancer. Asian Pac J Cancer Prev. 2005;6(4):490-496.
6. Nguyen JY, Major JM, Knott CJ, Freeman KM, Downs TM. Adoption of a plant-based diet by patients with recurrent prostate cancer. Integr Cancer Ther. 2006;5(3):214-223. 
7. Hodge AM, English DR, McCredie MR, Severi G, Boyle P, Hopper JL, et al. Foods, nutrients and prostate cancer. Cancer Causes Control. 2004;15(1):11-20. 8. Deneo-Pellegrini H, De Stefani E, Ronco A, Mendilaharsu M. Foods, nutrients and prostate cancer: a case-control study in Uruguay. Brit J Cancer, 1999;80(3-4):591-597.
9. Pierce JP, Faerber S, Wright FA, Rock, CL, Newman V, Flatt SW, et al. A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study. Control Clin Trials. 2002;23(6):728-756.
10. Pelucchi C, Talamini R, Galeone C, Negri E, Franceschi S, Dal Maso L, et al. Fibre intake and prostate cancer risk. Intl J Cancer. 2004;109(2):278-280.

11. Tymchuk CN, Barnard RJ, Heber D, Aronson WJ. Evidence of an inhibitory effect of diet and exercise on prostate cancer cell growth. J Urol. 2001;166(3):1185-1189.
12. Hebert JR, Hurley TG, Olendzki BC, Teas J, Ma Y, Hampl JS, et al. Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. J Natl Cancer Inst. 1998;90:1637-1647.
13. Harris PJ, Roberton AM, Watson ME, Triggs CM, Ferguson LR. The effects of soluble-fiber polysaccharides on the adsorption of a hydrophobic carcinogen to an insoluble dietary fiber. Nutr Cancer. 1993;19(1):43-54.
14. Slavin JL. Mechanisms for the impact of whole grain foods on cancer risk. Journal of the Am Coll Nutr. 2000;19(3 Suppl):300S-307S.
15. Chatenoud L, La Vecchia C, Franceschi S, Tavani A, Jacobs DRJ, Parpinel MT, et al. Refined- cereal intake and risk of selected cancers in Italy. Am J Clin Nutr. 1999; 70:1107-1110.
16. Deneo-Pellegrini H, De Stefani E, Ronco A, Mendilaharsu M. Foods, nutrients and prostate cancer: a case-control study in Uruguay. Brit J Cancer, 1999;80(3-4):591-597.
17. Dewell A, Weidner G, Sumner MD, Barnard RJ, Marlin RO, Daubenmier JJ, Chi C, Carroll PR, Ornish D. Relationship of dietary protein and soy isoflavones to serum IGF-1 and IGF binding proteins in the Prostate Cancer Lifestyle Trial. Nutr Cancer. 2007;58(1):35-42.
18. Aksoy Y, Aksoy H, Bakan E, Atmaca AF, Akcay F. Serum insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in localized, metastasized prostate cancer and benign prostatic hyperplasia. Urol Intl. 2004;72(1):62-65.
19. Barnard RJ, Ngo TH, Leung PS, Aronson WJ, Golding LA. A low-fat diet and/or strenuous exercise alters the IGF axis in vivo and reduces prostate tumor cell growth in vitro. Prostate. 2003;56(3):201-206.
20. Moyad MA. The use of complementary/preventive medicine to prevent prostate cancer recurrence/progression following definitive therapy: part I--lifestyle changes. Curr Opin Urol. 2003;13(2):137-145.

21. Venkateswaran V, Haddad AQ, Fleshner NE, Fan R, Sugar LM, Nam R, Klotz LH, Pollak M. Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts. J Natl Cancer Inst. 2007;99(23):1793-1800.
22. Fleshner N, Bagnell PS, Klotz L, Venkateswaran V. Dietary fat and prostate cancer. J Urol. 2004;171(2 Pt 2):S19-S24.
23. Colli JL, Colli A. Comparisons of prostate cancer mortality rates with dietary practices in the United States. Urol Oncol. 2005;23(6):390-398.
24. Williams GM, Williams CL, Weisburger JH. Diet and cancer prevention: the fiber first diet. Toxicol Sci. 1999;52(2 Suppl):72-86.
25. Ritch CR, Wan RL, Stephens LB, Taxy JB, Huo D, Gong EM, Zagaja GP, Brendler CB. Dietary fatty acids correlate with prostate cancer biopsy grade and volume in Jamaican men. J Urol. 2007;177(1):97-101.
26. Dewell A, Weidner G, Sumner MD, Barnard RJ, Marlin RO, Daubenmier JJ, Chi C, Carroll PR, Ornish D. Relationship of dietary protein and soy isoflavones to serum IGF-1 and IGF binding proteins in the Prostate Cancer Lifestyle Trial. Nutr Cancer. 2007;58(1):35-42.
27. Nowell S, Ratnasinghe DL, Ambrosone CB, Williams S, Teague-Ross T, Trimble L, et al. Association of SULT1A1 Phenotype and Genotype with Prostate Cancer Risk in African-Americans and Caucasians. Cancer Epidemiol Biomarkers Prev. 2004;13(2):270-276.
28. Hu JJ, Hall MC, Grossman L, Hedayati M, McCullough DL, Lohman K, et al. Deficient nucleotide excision repair capacity enhances human prostate cancer risk. Cancer Res. 2004;64(3):1197-1201.
29. Ferguson LR. Meat consumption, cancer risk and population groups within New Zealand. Mutation Res. 2002;506-507:215-224.
30. Koutros S, Cross AJ, Sandler DP, Hoppin JA, Ma X, Zheng T, Alavanja MC, Sinha R Meat and meat mutagens and risk of prostate cancer in the agricultural health study. Cancer Epidemiol Biomarkers Prev. 2008;17(1):80-87.

31. Bogen KT, Keating GA 2nd, Chan JM, Paine LJ, Simms EL, Nelson DO, Holly EA. Highly elevated PSA and dietary PhIP intake in a prospective clinic-based study among African Americans. Prostate Cancer Prostatic Dis. 2007;10(3):261-269.
32. Tseng M, Breslow RA, Graubard BI, Ziegler RG. Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohort. Am J Clin Nutr. 2005;81(5):1147-1154.
33. Ahn J, Albanes D, Peters U, Schatzkin A, Lim U, Freedman M, Chatterjee N, Andriole GL, Leitzmann MF, Hayes RB; for the Prostate, Lung, Colorectal, and Ovarian Trial Project Team. Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2007;16(12):2623-2630.
34. Park Y, Mitrou PN, Kipnis V, Hollenbeck A, Schatzkin A, Leitzmann MF. Calcium, dairy foods, and risk of incident and fatal prostate cancer: the NIH-AARP Diet and Health Study. Am J Epidemiol. 2007;166(11):1270-1279.
35. Gao X, LaValley MP, Tucker KL. Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J Natl Cancer Inst. 2005;97(23):1768-1777.
36. Giovannucci E, Liu Y, Stampfer MJ, Willett WC. A prospective study of calcium intake and incident and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006;15(2):203-210.
37. Grant WB. An ecologic study of dietary links to prostate cancer. Altern Med Rev. 1999;3:162-169.
38. Kesse E, Bertrais, Astorg P, Jauoen A, Arnault N. Dairy products, calcium and phosphorus intake, and the risk of prostate cancer: results of the French prospective SU.VI.MAX (Supplementation en Vitamines et Mineraux Antioxydants) study. Br J Nutr. 2006;95(3):539-545.
39. Gunnell D, Oliver SE, Peters TJ, Donovan JL, Persad R, Maynard M, et al. Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men. Br J Cancer. 2003;88(11):1682-1686.
40. Park SY, Murphy SP, Wilkens LR, Stram DO, Henderson BE, Kolonel LN. Calcium, vitamin D, and dairy product intake and prostate cancer risk: the Multiethnic Cohort Study. Am J Epidemiol. 2007;166(11):1259-1269.

41. Peehl DM, Krishnan AV, Feldman D. Pathways mediating the growth-inhibitory actions of vitamin D in prostate cancer. J Nutr. 2003;133(7 Suppl):2461S-2469S.
42. Chen TC, Wang L, Whitlatch LW, Flanagan JN, Holick MF. Prostatic 25-hydroxyvitamin D-1alpha-hydroxylase and its implication in prostate cancer. J Cell Biochem. 2003;88(2):315-322.
43. Gross C, Stamey T, Hancock S, Feldman D. Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol). J Urol. 1998;159(6):2035-2039.
44. Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control. 2000;11(9):847-852.
45. Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Intl J Cancer. 2004;108(1):104-108.
46. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006;98(7):451-459.
47. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, et al. Hypovitaminosis D in medical inpatients. New Engl J Med. 1998;338:777-778.
48. Rasmussen LB, Hansen GL, Hansen E, Koch B, Mosekilde L, Molgaard C, et al. Vitamin D: should the supply in the Danish population be increased? Intl J Food Sci Nutr. 2000;51(3):209-215.
49. Webb AR, Pilbeam C, Hanafin N, Holick MF. An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Amer J Clin Nutr. 1990;51:1075-1081.
50. Silverberg SJ, Shane E, de la Cruz L, Segre CV, Clemens TL, Bilezikian JP, et al. Vitamin D hydroxylation abnormalities in parathyroid hormone secretion and 1,25-dihydroxyvitamin D-3 formation in women with osteoporosis. New Engl J Med. 1989;320:277-281.

51. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84(1):18-28. 52. Demark-Wahnefried W, Moyad MA. Dietary intervention in the management of prostate cancer. Curr Opin Urol. 2007;17(3):168-174.
53. Freedland SJ, Platz EA. Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev. 2007;29:88-97.
54. BaÄħez LL, Hamilton RJ, Partin AW, Vollmer RT, Sun L, Rodriguez C, Wang Y, Terris MK, Aronson WJ, Presti JC Jr, Kane CJ, Amling CL, Moul JW, Freedland SJ. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA. 2007;298(19):2275-2280.
55. Bassett WW, Cooperberg MR, Sadetsky N, Silva S, DuChane J, Pasta DJ, Chan JM, Anast JW, Carroll PR, Kane CJ. Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE. Urol. 2005;66(5):1060-1065.
56. Schneider CM, Hsieh CC, Sprod LK, Carter SD, Hayward R. Cancer treatment-induced alterations in muscular fitness and quality of life: the role of exercise training. Ann Oncol. 2007;18(12):1957-1962.
57. Nilsen TI, Romundstad PR, Vatten LJ. Recreational physical activity and risk of prostate cancer: A prospective population-based study in Norway (the HUNT study). Int J Cancer. 2006;119(12):2943-2947.
58. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer. 2007;121(7):1571-1578.
59. Barnard RJ, Leung PS, Aronson WJ, Cohen P, Golding LA. A mechanism to explain how regular exercise might reduce the risk for clinical prostate cancer. Eur J Cancer Prev. 2007;16(5):415-421.
60. Tymchuk CN, Barnard RJ, Heber D, Aronson WJ. Evidence of an inhibitory effect of diet and exercise on prostate cancer cell growth. J Urol. 2001;166(3):1185-1189.

You are welcome to share this © article with friends, but do not forget to include the author name and web address. Permission needed to use articles on commercial and non commercial websites. Thank you.